Moderator: Edward J. Dohring, MD
9. Importance of cryoprotectant in bioavailability of cell-based matrices
Shabnam M. Namin, PhD1; Blake Martin, PhD2; renaud sicard, PhD3; Timothy Ganey, PhD4
1Vivex Biologics, Inc., Miami, FL, US; 2Vivex Biomedical, Atlanta, GA, US; 3Vivex, Biomedicals, Miami, FL, United States minor outlying islands; 4Tampa, FL, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
10. Multi-level anterior cervical discectomy and fusion (ACDF) with expandable cages for fixed kyphotic spondylotic myelo-radiculopathy obviating a posterior reconstruction
Kornelis A. Poelstra, MD, PhD1; Vicky Zhang, BS2; Anna Braun, ARNP3
1The Spine Institute on the Emerald Coast, Destin, FL, US; 2Atlas Spine Inc., Jupiter, FL, US; 3Destin, FL, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
11. Prone Transpsoas (PTP) approach to instrumented lumbar interbody fusion: Single-Position Surgery Maximizing Both Anterior and Posterior Column Access and Corrective Techniques
Luiz Pimenta, MD, PhD1; William R. Taylor, MD2; Samuel A. Joseph Jr. , MD3; Rodrigo A. Amaral, MD4; John G. Atwater, MD5; Ashish Patel, MD6; Noojan J. Kazemi, MD, FRACS7; Andrew C. Roeser, MD8; Antoine Tohmeh, MD9
1IPC, Sao Paulo, Brazil; 2University of California San Diego - Dept of Neurosurgery, La Jolla, CA, US; 3Joseph Spine Institute, Tampa, FL, US; 4IPC - Instituto de Patologia da Coluna, Sao Paulo, Brazil; 5Ortho-Spine Care America, Vero Beach, FL, US; 6Dupage Medical Group, Naperville, IL, US; 7Department of Neurosurgery, University of Arkansas Medical Sciences, Little Rock, AR, US; 8San Francisco, California, US; 9MultiCare Neuroscience Institute, Spokane Valley, WA, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
12. Cell potential derived from viable allograft: Histologic evidence from a retrieved spine implant device
Quante A. Singleton, MD1; William C. Tally, MD2; Shabnam M. Namin, PhD3; Timothy Ganey, PhD4
1Washington University at St. Louis , St. Louis , MO, US; 2Athenss Orthopedic Clinic, Athens, GA, US; 3Vivex Biologics, Inc., Miami, FL, US; 4Tampa, FL, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion, Questions & Answers
13. Bone-anchored annular closure reduces long-term symptomatic recurrent herniation and reoperation compared to discectomy alone during a randomized controlled trial in a high-risk patient population
Mark P. Arts, MD, PhD1; Gerrit J. Bouma, MD2; Claudius Thome, MD, PhD3
1Haaglanden Medical Center, The Hague, ZH, Netherlands; 2Univ Of Amsterdam - AMC, Amsterdam, DE, Netherlands; 3Medical University Innsbruck, Innsbruck, Austria
FDA Device/Drug Status: Barricaid®, Intrinsic Therapeutics (Approved for this indication)
14. A novel compressible core artificial cervical disc compared to anterior cervical discectomy and fusion: Two-year clinical results
Richard D. Guyer, MD1; Scott L. Blumenthal, MD2; Jack E. Zigler, MD2; Jessica Shellock, MD2; Frank M. Phillips, MD5; Domagoj Coric, MD6; Frank P. Cammisa, MD3; Rick C. Sasso, MD4
1Center for Disc Replacement at Texas Back Institute, Plano, TX, US; 2Texas Back Institute, Plano, TX, US; 3The Hospital for Special Surgery, New York, NY, US; 4Indiana Spine Group, Carmel, IN, US; 5Midwest Orthopaedics At Rush, Chicago, IL, US; 6Carolina Neurosurgery & Spine Associates, Charlotte, NC, US
FDA Device/Drug Status: M6-C Cervical disc (Approved for this indication)
15. What drives spinal fusion within graft materials, cells or growth factors?
Aidin Abedi, MD1; Blake G. Formanek2; Nick A. Russell, PhD3; Frank Vizesi, PhD4; Scott D. Boden, MD5; Jeffrey C. Wang, MD6; Zorica Buser, PhD7
1Dept of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, US; 2University of Southern California, Los Angeles, CA, US; 3; 4SeaSpine, Carlsbad, CA, US; 5The Emory Spine Center, Atlanta, GA, US; 6USC Spine Center, Los Angeles, CA, US; 7Keck School of Medicine, University of Southern California, Los Angeles, CA, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion, Questions & Answers